EFFECTS OF ANTIOXIDANTS AND PAF RECEPTOR ANTAGONIST IN INTESTINAL SHOCK IN THE RAT

被引:0
|
作者
HAGLIND, E [1 ]
XIA, GC [1 ]
RYLANDER, R [1 ]
机构
[1] UNIV GOTEBORG, DEPT ENVIRONM MED, GOTHENBURG, SWEDEN
关键词
HYPOVOLEMIA; MUCOSAL LESION; ENDOTOXIN; REPERFUSION; PAF;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a model of intestinal ischemia-reperfusion resulting in hypotension, mucosal lesions in the small intestine and mortality, the effects of a combination of superoxide dismutase (SOD) and catalase (cat) or a PAF receptor antagonist were tested. Intestinal ischemia was induced in rats and continued for 60 min. After this, the intestine was reperfused. A PAF receptor antagonist, BN 52021, was given 50 min before ischemia in one group, and SOD + cat was given 10 min before reperfusion in one group. One group received normal saline and one group were controls. Blood pressure, mucosal lesions, plasma volume, and endotoxin in plasma were determined up to 3 hr after reperfusion. Mortality was determined over 4 days. Endogenous endotoxin was not found in any of the groups, but the first types of SOD and cat used were contaminated with endotoxin, resulting in exogenous endotoxemia in animals which received those substances. Later endotoxin-free enzymes were used. Neither SOD + cat nor PAF antagonist had any effect on the hypotension or mucosal lesions. Plasma volume remained at the level of the control group after administration of either regimen. Mortality decreased in the group that received SOD + cat. The effects of SOD + cat indicate that free radicals were released in this model at reperfusion, and the effects of the PAF receptor antagonist indicate that PAF participates in membrane damage, but is an intermediary mechanism in the shock model used. The clearance of infused endotoxin from plasma was less effective in the shocked animals, possibly due to a shock effect on reticuloendothelial system (RES). Clinically, the results are interesting in intestinal ischemia-reperfusion. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 50 条
  • [21] Bakkenolide G, a natural PAF-receptor antagonist
    Liao, CH
    Ko, FN
    Wu, TS
    Teng, CM
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (12) : 1248 - 1253
  • [22] Effects of topical platelet activating factor (PAF) antagonist on a rat model of penetrating keratoplasty
    Pena, RA
    Frank, K
    Croft, KW
    Dieckert, JP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3992 - 3992
  • [23] EFFECTS OF A PAF ANTAGONIST ON IGE ANAPHYLAXIS IN RABBITS
    LOHMAN, IC
    HALONEN, M
    FASEB JOURNAL, 1988, 2 (05): : A1577 - A1577
  • [24] EFFECTS OF WEB-2086, AN ANTAGONIST TO THE RECEPTOR FOR PLATELET-ACTIVATING-FACTOR (PAF), ON PAF-INDUCED RESPONSES IN THE HORSE
    FOSTER, AP
    LEES, P
    ANDREWS, MJ
    CUNNINGHAM, FM
    EQUINE VETERINARY JOURNAL, 1992, 24 (03) : 203 - 207
  • [25] BRONCHIAL AND VASCULAR EFFECTS OF PAF IN THE RAT ISOLATED LUNG ARE COMPLETELY BLOCKED BY WEB-2086, A NOVEL SPECIFIC PAF ANTAGONIST
    CASALSSTENZEL, J
    FRANKE, J
    FRIEDRICH, T
    LICHEY, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (04) : 799 - 802
  • [26] INHIBITION OF THROMBOXANE AND PAF-ACETHER BIOSYNTHESIS ATTENUATES RAT INTESTINAL DAMAGE IN ENDOTOXIN-SHOCK
    WHITTLE, BJR
    BOUGHTONSMITH, NK
    GASTROENTEROLOGY, 1988, 94 (05) : A495 - A495
  • [27] THE EFFECT OF PAF-RECEPTOR ANTAGONIST KADSURENONE ON THE CARDIOVASCULAR EFFECTS IN THE RABBIT INFUSED WITH SYNTHETIC PLATELET-ACTIVATING FACTOR (PAF)
    MONTRUCCHIO, G
    ALLOATTI, G
    MARIANO, F
    SHEN, TY
    TETTA, C
    RAGNI, R
    MEDA, E
    EMANUELLI, G
    CAMUSSI, G
    PROSTAGLANDINS, 1985, 30 (04): : 711 - 711
  • [28] Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat
    Souza, DG
    Cara, DC
    Cassali, GD
    Coutinho, SF
    Silveira, MR
    Andrade, SP
    Poole, SP
    Teixeira, MM
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (08) : 1800 - 1808
  • [29] PROTECTIVE EFFECTS OF A SPECIFIC PLATELET ACTIVATING FACTOR (PAF) ANTAGONIST, WEB-2086, IN TRAUMATIC SHOCK
    STAHL, GL
    BITTERMAN, H
    LEFER, AM
    THROMBOSIS RESEARCH, 1989, 53 (03) : 327 - 338
  • [30] Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats
    Sun, ZW
    Wang, XD
    Deng, XM
    Lasson, Å
    Soltesz, V
    Börjesson, A
    Andersson, R
    DIGESTIVE SURGERY, 2000, 17 (01) : 57 - 65